Interstitial lung disease: a review of classification, etiology, epidemiology, clinical diagnosis, pharmacological and non-pharmacological treatment

Malik A Althobiani, Anne-Marie Russell, Joseph Jacob, Yatharth Ranjan, Amos A Folarin, John R Hurst, Joanna C Porter

Research output: Contribution to journalReview articlepeer-review

Abstract

Interstitial lung diseases (ILDs) refer to a heterogeneous and complex group of conditions characterized by inflammation, fibrosis, or both, in the interstitium of the lungs. This results in impaired gas exchange, leading to a worsening of respiratory symptoms and a decline in lung function. While the etiology of some ILDs is unclear, most cases can be traced back to factors such as genetic predispositions, environmental exposures (including allergens, toxins, and air pollution), underlying autoimmune diseases, or the use of certain medications. There has been an increase in research and evidence aimed at identifying etiology, understanding epidemiology, improving clinical diagnosis, and developing both pharmacological and non-pharmacological treatments. This review provides a comprehensive overview of the current state of knowledge in the field of interstitial lung diseases.

Original languageEnglish
Article number1296890
Pages (from-to)1296890
JournalFrontiers in Medicine
Volume11
DOIs
Publication statusPublished - 2024

Fingerprint

Dive into the research topics of 'Interstitial lung disease: a review of classification, etiology, epidemiology, clinical diagnosis, pharmacological and non-pharmacological treatment'. Together they form a unique fingerprint.

Cite this